ChiCTR2300069688 版本V1.1 版本创建时间2023/05/26 20:44:48 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300069688 

最近更新日期:

Date of Last Refreshed on:

2023-03-23 14:23:21 

注册时间:

Date of Registration:

2023-03-23 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

高原脱适应期心血管系统、精神心理疾病的治疗策略研究

Public title:

Study on the therapeutic strategies of cardiovascular system and psychological disorders during high-altitude deacclimatization

注册题目简写:

English Acronym:

研究课题的正式科学名称:

高原脱适应期心血管系统、精神心理疾病的治疗策略研究

Scientific title:

Study on the therapeutic strategies of cardiovascular system and psychological disorders during high-altitude deacclimatization

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨杰 

研究负责人:

晋军 

Applicant:

Jie Yang 

Study leader:

Jun Jin 

申请注册联系人电话:

Applicant telephone:

18623330911

研究负责人电话:

Study leader's
telephone:

13272605717

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yangjie0818@hotmail.com

研究负责人电子邮件:

Study leader's E-mail:

372534493@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市沙坪坝区新桥正街183号

研究负责人通讯地址:

重庆市沙坪坝区新桥正街183号

Applicant address:

183 Xinqiao Zhengjie, Shapingba District, Chongqing

Study leader's address:

183 Xinqiao Zhengjie, Shapingba District, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

陆军军医大学第二附属医院

Applicant's institution:

Second Hospital of the Army Medical University

研究负责人所在单位:

陆军军医大学第二附属医院

Affiliation of the Leader:

Second Hospital of the Army Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2022-研第505-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军陆军军医大学第二附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the Second Affiliated Hospital of PLA Army Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-23 00:00:00

伦理委员会联系人:

陈飞

Contact Name of the ethic committee:

Fei Chen

伦理委员会联系地址:

陆军军医大学第二附属医院药学部3楼伦理委员会办公室

Contact Address of the ethic committee:

Office of Ethics Committee,3rd Floor, Department of Pharmacy, Second Hospital Affiliated to Army Medical University

伦理委员会联系人电话:

Contact phone of the ethic committee:

023 68755422

伦理委员会联系人邮箱:

Contact email of the ethic committee:

liuzhen_enjoy@163.com

研究实施负责(组长)单位:

陆军军医大学第二附属医院

Primary sponsor:

Second Hospital of the Army Medical University

研究实施负责(组长)单位地址:

重庆市沙坪坝区新桥正街183号

Primary sponsor's address:

183 Xinqiao Zhengjie, Shapingba District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

沙坪坝

Country:

China

Province:

Chongqing

City:

Shapingba

单位(医院):

陆军军医大学第二附属医院

具体地址:

重庆市沙坪坝区新桥正街183号

Institution
hospital:

Second Hospital of the Army Medical University

Address:

183 Xinqiao Zhengjie, Shapingba District, Chongqing

经费或物资来源:

军队后勤科研重点项目

Source(s) of funding:

Key military logistics research projects

研究疾病:

高原脱适应期心血管系统、精神心理疾病  

Target disease:

Cardiovascular system and psychological disorders during high-altitude deacclimatization

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

1、探究高原脱适应症发病特点 2、探究针对高原脱适应症的治疗策略 3、明确高原脱适应期心血管疾病发病特点 4、明确高原脱适应期精神心理疾病的发病规律  

Objectives of Study:

1. Explore the characteristics of high-altitude deacclimatization 2. Explore therapeutic strategies for high-altitude deacclimatization 3. Clarify the characteristics of cardiovascular diseases during the high-altitude deacclimatization 4. Clarify the occurrence regularity of mental diseases during the high-altitude deacclimatization

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)5年内从高原返回平原地区的部队官兵;
(2)年龄在18-60岁之间的人群;
(3)受试者提供书面知情同意

Inclusion criteria

(1) Troops returning from the high altitude to the plain within 5 years;
(2) People aged between 18 and 60;
(3) The subject endorsed informed consent.

排除标准:

(1)患有恶性肿瘤;
(2)罹患传染性疾病;
(3)拒绝的受试人群。

Exclusion criteria:

(1) Suffering malignant tumor;
(2) Suffering from infectious diseases;
(3) Subjects who refused.

研究实施时间:

Study execute time:

From 2023-04-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-04-01 00:00:00 To 2023-06-01 00:00:00

干预措施:

Interventions:

组别:

营养心肌组

样本量:

50

Group:

Nutritional myocardium group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nothing

Intervention code:

组别:

抗心律失常药物组

样本量:

50

Group:

Antiarrhythmic drugs group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nothing

Intervention code:

组别:

钙离子拮抗剂组

样本量:

50

Group:

Calcium antagonist group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nothing

Intervention code:

组别:

RAAS系统拮抗剂药组

样本量:

50

Group:

RAAS system antagonist group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nothing

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

沙坪坝 

Country:

China

Province:

Chongqing

City:

Shapingba

单位(医院):

陆军军医大学第二附属医院 

单位级别:

三甲 

Institution
hospital:

Second Hospital of the Army Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

心脏超声

指标类型:

主要指标

Outcome:

Echocardiography

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心电图

指标类型:

主要指标

Outcome:

Electrocardiogram

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

主要指标

Outcome:

Blood pressure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血氧饱和度

指标类型:

主要指标

Outcome:

Oxygen saturation

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心衰、心梗标志物

指标类型:

主要指标

Outcome:

Markers of heart failure and myocardial infarction

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血常规

指标类型:

主要指标

Outcome:

Blood routine

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肝功、肾功

指标类型:

主要指标

Outcome:

Liver and kidney function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心肺运动实验

指标类型:

主要指标

Outcome:

Cardiopulmonary exercise test

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

静脉血

组织:

Sample Name:

Vein blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

Nothing

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

NCBI数据库,2024年6月1日,https://www.ncbi.nlm.nih.gov

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

NCBI database,1st Jun 2024,https://www.ncbi.nlm.nih.gov

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集采用陆军军医大学第二附属医院住院病人管理系统及手术病人管理系统,将临床收集的病例转为病例报告表,报告表的纸质版和实验记录放于第二附属医院心血管内科实验室保管;实验室专人对患者临床资料病例报告表的电子版和纸质版及实验记录进行归档、管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data were collected and registered by the inpatient management system and surgical patient management system of the Second Affiliated Hospital of Army Military Medical University. Clinical cases were converted into case report forms, and paper versions of the report forms and experimental records were placed in the Laboratory of Cardiovascular Medicine of the Second Affiliated Hospital for safekeeping. Special personnel in the laboratory will archive and manage the electronic and paper versions of patient clinical data case report forms and experimental records.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-03-23 14:22:48